Avanos Medical Inc (AVNS)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$11.00
Buy
$12.08
$0.05 (+0.43%)
Prices updated at 17 Dec 2025, 23:28 EST
| Prices minimum 15 mins delay
Prices in USD
Halyard Health Inc is a medical technology company which provides healthcare supplies and solutions that target the prevention of healthcare associated infections. Its business segments include Surgical and Infection Prevention and Medical Devices.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 673m | 688m | |
| 380m | 381m | |
| 4m | 41m | |
| 0.62 | 5.89 | |
| -62m | -392m | |
| 53m | -346m | |
| Sales, General and administrative | 335m | 319m |
| Interest expenses | 15m | 12m |
| Provision for income taxes | 2m | -17m |
| Operating expenses | 376m | 341m |
| Income before taxes | -8m | -403m |
| Net income available to common shareholders | -62m | -392m |
| -1.32 | -8.53 | |
| Net interest income | -12m | -7m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -1.32 | -8.53 |
| Free cash flow per share | 0.7837 | 0.7879 |
| Book value/share | 26.4671 | 26.7543 |
| Debt equity ratio | 0.151824 | 0.180929 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 487m | 393m |
| Current liabilities | 235m | 166m |
| Total capital | 1,396m | 954m |
| Total debt | 209m | 170m |
| Total equity | 1,236m | 829m |
| Total non current liabilities | - | - |
| Loans | 159m | 125m |
| Total assets | 1,692m | 1,154m |
| Total liabilities | - | - |
| Cash and cash equivalents | 88m | 108m |
| Common stock | 46m | 46m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 128m | 88m |
| Cash dividends paid | - | - |
| 15m | 83m | |
| Investments (gains) losses | 22m | -27m |
| 88m | 108m | |
| Net income | - | - |
| 32m | 101m | |
| -18m | -18m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.